Liu, Chun-Yu <br/><br/>
Targeting SET to restore PP2A activity disrupts an oncogenic CIP2A-feedforward loop and impairs triple negative breast cancer progression.  [electronic resource] 

 -  EBioMedicine  Feb 2019 
 - 263-275 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>2352-3964 
<br/><br/><label>Standard No.: </label>10.1016/j.ebiom.2018.12.032  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apoptosis--drug effects<br/>Autoantigens--genetics<br/>Cell Line, Tumor<br/>Cell Survival--drug effects<br/>Cisplatin--pharmacology<br/>DNA-Binding Proteins<br/>Disease Models, Animal<br/>Erlotinib Hydrochloride--pharmacology<br/>Extracellular Signal-Regulated MAP Kinases--antagonists & inhibitors<br/>Female<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Histone Chaperones--metabolism<br/>Humans<br/>Intracellular Signaling Peptides and Proteins<br/>Membrane Proteins--genetics<br/>Mice<br/>Models, Biological<br/>Promoter Regions, Genetic<br/>Protein Kinase Inhibitors--pharmacology<br/>Protein Phosphatase 2--metabolism<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Signal Transduction--drug effects<br/>Transcription Factors--metabolism<br/>Triple Negative Breast Neoplasms--genetics<br/>Xenograft Model Antitumor Assays